
InnovationMore in Innovation→
Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot
Key Takeaways
- Moderna and Merck are avoiding the word vaccine for a personalized cancer shot.
- The treatment uses mRNA to train the immune system against tumor neoantigens.
- Political pressure around vaccines is influencing biotech vocabulary.
DE
DT Editorial Team··via technologyreview.com


